17 January 2022 in Neuroscience Letters
3 February 2024 in Pflügers Archiv - European Journal of Physiology
1 January 2023 in Geriatrics Gerontology and Aging
Objective: To describe the safety of medicines available in the “Brazilian List of Essential Medicines” (RENAME/2022) for the main comorbidities that affect older persons according to the Beers criteria 2019. Methods: Medicines listed in RENAME and recommended by the respective Brazilian medical guidelines for the treatment of hypertension, heart failure, diabetes, and neurological/ psychiatric diseases were evaluated for their safety profiles according to the Beers criteria 2019. Results: Fifty-eight out of 529 medicines in RENAME were evaluated. Of these, 29 were included in any of the Beers criteria: 20 were classified as potentially inappropriate, 17 should be avoided due to disease exacerbation, and 14 needed to be used with caution. Considering drugs used to treat cardiovascular, diabetes, and neurological/psychiatric disorders, 40.00, 37.50 and 60.00% respectively, had some criterion for their appropriate use in older persons. Conclusion: RENAME presents alternatives for the safe treatment of older patients. In the treatment of cardiovascular diseases, diabetes, and neurodegenerative diseases, the firstchoice recommendations are available in RENAME. Regarding psychiatric disorders, safe pharmacological alternatives are still scarce and need to be better discussed.
2 May 2024 in Advances in Research
Aims: Due the pandemic of the new coronavirus (COVID-19), stricter measures to limit unessential interactions were adopted, including the suspension of classroom lessons and the implementation of the distance learning regime. As these restrictions change lifestyles, this study aimed to assess the impacts of social distancing on mental health and sleep quality in medical students during the COVID-19 pandemic. Study Design: Cross-sectional study. Place and Duration of Study: Medical school in Goiânia, Goiás, Brazil. Data collection took place from June 1 to July 1, 2020. Methodology: This study used self-administered questionnaires answered by students from a Public University in Brazil. The collection instrument consisted of four parts: socioeconomic variables, self-perception of health, Self-Report Questionnaire (SRQ-20), and Pittsburgh Sleep Quality Index (PSQI). Absolute and relative frequencies described the sample, Chi-square test and Student’s t-test tested associations between the variables, Pearson’s correlation tested the relationship between PSQI and SRQ-20. Results: Of the 210 participants, 138 students (65.7%) had scores suggestive of mental distress by the SRQ-20; women had a higher risk when compared to men (women 67.7% vs. men 49%, p < .01). 186 students (88.6%) had poor sleep quality according to the PSQI; women also had higher sleep disturbance (women 1.26 ± 0.06 vs. men 1.35 ± 0.04, p < .05). Mental distress measures were positively correlated with sleep quality (r = 0.611, p < .001). Conclusion: The strict preventive measures, and the radical changes in the lifestyle of medical students had a negative impact on the quality of their sleep and mental state. The students showed high levels of mental distress and poor sleep quality, and women appear to be an important risk factor. Implementation of interventions for well-being in pandemic condition by universities, and special focus to the most affected groups (such as women), should be stimulated.
4 November 2025 in Nutritional Neuroscience
The endocannabinoid system (ECS) plays a pivotal role in regulating energy balance. While ECS activation stimulates appetite and increases preference for palatable food, it also enhances energy expenditure by motivating physical activity. This study investigated the impact of two key energy balance modulators - consumption of a palatable diet and the practice of aerobic physical activity - on the expression of CB1 receptor and NAPE-PLD enzyme in the rat brain. Male Wistar rats, weaned at 3 weeks, were divided into 4 groups: standard-diet untrained, standard-diet trained, palatable-diet untrained, and palatable-diet trained. Trained groups underwent treadmill exercise while the palatable diet groups were fed accordingly. After 8 weeks, rats were euthanized for blood and brain collection. Western blotting assessed CB1 and NAPE-PLD proteins expression in the frontal cortex, hypothalamus, and preoptic area. Physical performance, body weight, adiposity index, and plasma levels of leptin, insulin, and glucose were measured. Aerobic training enhanced physical performance, while a palatable diet increased the adiposity index and plasma leptin levels. In the hypothalamus, both interventions reduced CB1 and NAPE-PLD proteins, while increasing them in the frontal cortex. Physical training and the palatable diet decreased NAPE-PLD in the preoptic area. These findings indicate that exposure to a palatable diet and aerobic training during early life exerts distinct effects on ECS signaling within the central nervous system. This study provides novel evidence that dietary and physical activity patterns can differentially shape brain ECS components, offering insights into their potential roles in energy homeostasis and obesity development.
17 January 2022 in Tropical Doctor
Ours is a cross-sectional, descriptive, retrospective study evaluating the extent of off-label prescribing for patients attending a university paediatric outpatient department in Goiás, Brazil. 391 patients were treated in the outpatient, and 668 medicines were prescribed. Of these, 70.4% followed the terms of the marketing authorization; 0.3% were unlicenced, and 11% were off-label. Dose was the main factor in off-label prescribing. Infants (0–2 years) received 37.8% of the off-label prescriptions. Vitamins and drugs for the treatment of respiratory diseases were the most prevalent culprits. Of the total prescriptions, 23 different drugs were defined as off-label. Salbutamol was the most prescribed (41.9%). Owing to practical and legal difficulties in carrying out clinical trials, medicines are inadequately studied in children; cooperation between industry, regulatory authorities, and healthcare professionals is required to improve treatment safety. Our results may help guide clinical researcher on off-label prescripting in future trials.